LBRX
LB Pharmaceuticals Inc
37.30$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +4.9% | -3.5% | +18.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +56.1% | -56.4% | -96.5% | +676.9% | +0.0% | -17.2% | +250.7% | +72.6% | +201.4% | – | |
| – | +121.5% | +155.4% | -4.6% | -51.9% | +0.0% | +13.9% | +90.6% | +38.5% | +31.0% | – | |
| – | +59.9% | -39.5% | -65.5% | +1.9% | +0.0% | -7.1% | +164.4% | +58.8% | +144.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.